title: Treatment of polycystic liver disease with resection-fenestration and a new classification.
abstract: OBJECTIVE
  To evaluate outcomes in patients with autosomal dominant polycyst liver disease (APLD) treated by combined hepatic resection and fenestration. A new classification was recommended to presume postoperative complications and long outcome of patients.
  
  
  METHODS
  Twenty-one patients with APLD were treated by a combined hepatic resection and fenestration technique. All patients were reviewed retrospectively, and clinical symptoms, performance status and morbidity were recorded. A new classification of APLD is recommended here.
  
  
  RESULTS
  All patients were discharged when free of symptoms. The mean follow-up time was 55.7 mo and three patients had a recurrence of symptoms at 81, 68 and 43 mo after operation, respectively. The overall morbidity rate was 76.2%. Two patients with Type B-II and Type B-I developed biliary leakage. Four patients had severe ascites, including three with Type B-III and one with Type B-II. Nine patients had pleural effusion, including one with Type A-I; one with Type B-I; five with Type B-II; one with Type A-III and one with Type B-III. Three patients with Type B had recurrence of symptoms, while none with Type A had severe complications.
  
  
  CONCLUSIONS
  Combined hepatic resection and fenestration is an acceptable procedure for treatment of APLD. According to our classification, postoperative complications and long outcome can be predicted before surgery.
authors.affiliation: Eastern Hepato-biliary Hospital, Second Military Medical University, Shanghai, China.
authors.forename: Tuan-Jie
authors.initials: TJ
authors.lastname: Li
authors.forename: Hai-Bin
authors.initials: HB
authors.lastname: Zhang
authors.forename: Jun-Hua
authors.initials: JH
authors.lastname: Lu
authors.forename: Jun
authors.initials: J
authors.lastname: Zhao
authors.forename: Ning
authors.initials: N
authors.lastname: Yang
authors.forename: Guang-Shun
authors.initials: GS
authors.lastname: Yang